Dr. Morrison has made significant holdings at Syndax Pharmaceuticals. He once held RSUs worth approximately $1.26 million when they vested in 2020. At his peak in 2021, his holdings were substantial, but he has since focused more on his research...
Dr. Morrison has made significant holdings at Syndax Pharmaceuticals. He once held RSUs worth approximately $1.26 million when they vested in 2020. At his peak in 2021, his holdings were substantial, but he has since focused more on his research and development responsibilities. His investments have seen highs and lows, reflecting the volatility in the pharma sector. Currently, he continues to benefit from his equity awards as he transitions into a new role within the company, keeping alignment with his long-term interests in Syndax.